Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating Activities
Net income	$ 23,943	$ 13,991
Items not requiring (providing) cash
Provision for credit losses	1,376	805
Depreciation and amortization	2,475	2,649
Share based compensation	459	907
Amortization of mortgage servicing rights	507	476
Net amortization of premiums and discounts on securities	1,885	2,182
Loss on sale of investment securities	407	0
Gain on sale of mortgage loans	(1,076)	(626)
Gain on sale of portfolio loans	(7,000)	0
Proceeds from sales of loans	26,073	21,432
Loans originated for sale	(26,407)	(20,517)
Gain on cash value life insurance	(335)	(298)
Gain on other real estate owned	(13)	(64)
Net change in:
Interest receivable	1,084	(1,298)
Interest payable	304	(14,396)
Other assets	9,741	(4,548)
Other liabilities	(18,178)	5,849
Net cash provided by operating activities	15,244	6,544
Investing Activities
Proceeds from sales of securities available for sale	4,132	0
Proceeds from maturities, calls and principal repayments of securities available for sale	597	4,369
Proceeds from maturities of securities held to maturity	17,683	18,233
Net change in interest-earning time deposits	735	490
Purchase of FHLB stock	0	(19,317)
Redemption of FHLB stock	8,414	0
Purchase of loans	0	(153,743)
Proceeds from sale of portfolio loans	54,990	0
Net change in loans	(47,159)	(47,365)
Proceeds on the sale of OREO and repossessed assets	221	369
Premises and equipment expenditures	(1,129)	(1,178)
Proceeds from bank owned life insurance	376	22,917
Net cash provided by (used in) investing activities	38,860	(175,225)
Financing Activities
Net change in deposits	165,131	(85,023)
Proceeds from borrowings	200,000	403,026
Repayment of borrowings	(530,123)	(400,235)
Net change in repurchase agreements	(2,060)	3,280
Net settlement of share awards	(3,698)	(708)
Dividends paid on common stock	(7,120)	(7,086)
Net cash used in financing activities	(177,870)	(86,746)
Net Change in Cash and Cash Equivalents	(123,765)	(255,427)
Cash and Cash Equivalents, Beginning of Period	293,431	526,515
Cash and Cash Equivalents, End of Period	169,666	271,088
Additional Supplemental Information
Interest paid	36,605	56,372
Income taxes paid	360	0
Transfer of loans to other real estate and repossessed assets	1,034	253
Transfer of held to maturity securities to available for sale	4,539	0
Cash dividends declared, not paid	$ 7,088	$ 7,156